Fabbri A, Tacchella A, Belli M L, Losurdo G
II Clinica Malattie Infettive, Ospedale G. Gaslini, Genova, Italy.
Chemioterapia. 1988 Oct;7(5):306-8.
Minimum inhibitory concentrations (MICs) of ampicillin and ampicillin + sulbactam (1:1) against 165 strains of Staphylococcus aureus and 72 strains of Staphylococcus epidermidis have been evaluated. The activity of the combination was very good. A concentration of 16 micrograms/ml + 16 micrograms/ml inhibited 96.9% of S. aureus and the 100% of S. epidermidis strains (at the same concentration ampicillin alone inhibited only 55.15% and 56.9% of S. aureus and S. epidermidis strains respectively). Activity against methicillin-resistant S. aureus (14.5%) was poor, whereas against methicillin-resistant S. epidermidis (67.2%) the combination maintained high efficacy.
已评估了氨苄西林和氨苄西林+舒巴坦(1:1)对165株金黄色葡萄球菌和72株表皮葡萄球菌的最低抑菌浓度(MIC)。该联合用药的活性非常好。浓度为16微克/毫升+16微克/毫升时可抑制96.9%的金黄色葡萄球菌菌株和100%的表皮葡萄球菌菌株(相同浓度下,单独使用氨苄西林仅分别抑制55.15%的金黄色葡萄球菌菌株和56.9%的表皮葡萄球菌菌株)。对耐甲氧西林金黄色葡萄球菌(14.5%)的活性较差,而对耐甲氧西林表皮葡萄球菌(67.2%),该联合用药仍保持高效。